日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

儿童癌症协作组、儿科肿瘤协作组和儿童肿瘤协作组开展的七项II期临床试验中,复发性骨肉瘤患者的预后:从过去吸取经验教训,展望未来

Lagmay, Joanne P; Krailo, Mark D; Dang, Ha; Kim, AeRang; Hawkins, Douglas S; Beaty, Orren 3rd; Widemann, Brigitte C; Zwerdling, Theodore; Bomgaars, Lisa; Langevin, Anne-Marie; Grier, Holcombe E; Weigel, Brenda; Blaney, Susan M; Gorlick, Richard; Janeway, Katherine A

A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study

一项针对难治性实体瘤患儿的奥沙利铂II期临床试验和药代动力学研究:儿童肿瘤协作组研究

Beaty, Orren 3rd; Berg, Stacey; Blaney, Susan; Malogolowkin, Marcio; Krailo, Mark; Knight, Ronald; Schaiquevich, Paula; Stewart, Clinton; Chen, Zhengjia; Nelson, Marvin; Voss, Stephan; Ivy, S Percy; Adamson, Peter C